BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12502457)

  • 1. [Establishment of a cisplatin-induced resistant human hepatocellular carcinoma cell model and preliminary study on its resistant mechanisms].
    Yang J; Tang W
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):464-5. PubMed ID: 12502457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Establishment of a cisplatin-induced human hepatocellular carcinoma drug-resistant cell line and its biological characteristics].
    Yang JX; Tang WX
    Ai Zheng; 2002 Aug; 21(8):872-6. PubMed ID: 12478896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The interaction between 5-fluorouracil and marini on QGY cell line in vitro].
    He S; Cheb S; Tang W; Zuo G; Shen W
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):160. PubMed ID: 12108392
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
    Kubo K; Matsuzaki Y; Kato A; Terai S; Okita K
    Int J Oncol; 1999 Jan; 14(1):41-6. PubMed ID: 9863007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
    Yang JX; Luo Y; Qiu HM; Tang WX
    Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232.
    Diaconu CC; Szathmári M; Kéri G; Venetianer A
    Br J Cancer; 1999 Jun; 80(8):1197-203. PubMed ID: 10376972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
    Okamura M; Shimada J; Sakagami H
    Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
    Okamura M; Hashimoto K; Shimada J; Sakagami H
    Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.
    Lund P; Schubert D; Niketeghad F; Schirmacher P
    Cancer Lett; 2004 Mar; 206(1):85-96. PubMed ID: 15019164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on apoptosis of human hepatoma cell line HepG2 induced by oxaliplatin].
    Zhang Y; Zuo GQ; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):374-5. PubMed ID: 15225442
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stable inhibition of nuclear factor kappaB in SMMC7721 cells increases sensitivity to Doxorubicin].
    Wang JH; Huang QK; Chen MX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):375-6. PubMed ID: 15225443
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical application of vitamin K for hepatocellular carcinoma].
    Mizuta T; Ozaki I
    Clin Calcium; 2007 Nov; 17(11):1693-9. PubMed ID: 17982189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA].
    Ouyang GL; Li QF; Peng XX; Hong SG
    Shi Yan Sheng Wu Xue Bao; 2001 Dec; 34(4):269-73. PubMed ID: 12549204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma.
    Cheng AS; Wong N; Tse AM; Chan KY; Chan KK; Sung JJ; Chan HL
    Cancer Lett; 2007 Aug; 253(1):43-52. PubMed ID: 17296261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma.
    Tam KH; Yang ZF; Lau CK; Lam CT; Pang RW; Poon RT
    Cancer Lett; 2009 Jan; 273(2):201-9. PubMed ID: 18824293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate.
    Wang CT; Meng M; Zhang JC; Jin CJ; Jiang JJ; Ren HS; Jiang JM; Qin CY; Yu DQ
    Chin Med J (Engl); 2008 Sep; 121(17):1707-11. PubMed ID: 19024104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemosensitization of hepatocellular carcinoma using antisense oligonucleotides].
    Wang ZY; Lin RX; Wang SQ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):242, 246. PubMed ID: 16635287
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel phenotype-based approach for systematically screening antiproliferation metallodrugs.
    Wang YH; Cheng CC; Lee WJ; Chiou ML; Pai CW; Wen CC; Chen WL; Chen YH
    Chem Biol Interact; 2009 Nov; 182(1):84-91. PubMed ID: 19682442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of {2-[(3-carboxy-1-oxoprogy1)amino]-2-deoxy-D-glucose} on human hepatocellular carcinoma cell line.
    Wu J; Kou W; Gao MT; Zhou YN; Wang AQ; Xue QJ; Qiao L
    Acta Pharmacol Sin; 2005 May; 26(5):635-40. PubMed ID: 15842786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.